Fig. 2From: Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort studyRisk of incident subclinical atherosclerosis (composite/separate) for participants with fatty liver in relation to the number of metabolic abnormalities ORs (95% CIs) were adjusted for age, sex, follow-up interval, current smoking and drinking status (yes/no), education (≥ 12 years or not), log-transformed physical activity, baseline BMI and BMI change. NFL no fatty liver; FL fatty liver; DM diabetes mellitus; baPWV brachial–ankle pulse wave velocity; PP pressure pulse; OR odds ratio; CI confidential interval; BMI body mass index. *This group included type 2 diabetes participants with/without metabolic abnormalitiesBack to article page